CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship

The CancerConnect Lung Cancer Newsletter

TraceyS

Stay Current With Lung Cancer Treatment Advances & Connect with Others

CancerConnect Lung Cancer Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Lung Cancer. These are available in our monthly Lung Cancer newsletter.

Stay Current - Connect With Other Lung Cancer Patients

Join The CancerConnect Community: Connect with others and receive regular updates

or

Sign up for the Lung Cancer Newsletter Here

Comments

Lung Cancer

FEATURED
COMMUNITY

Treatment & Management of Non Small Cell Lung Cancer

Understand the role of precision cancer medicine, surgery, chemotherapy and radiation in the management of NSCLC.

Cancer Connect

Overview of Lung Cancer

Lung Cancer; Risk factors, diagnostic evaluation, staging and treatment planning.

Cancer Connect

Precision Cancer Medicines & Immunotherapy for Lung Cancer

Keep up with the growing number of precision medicines targeting specific mutations in lung cancer.

MedMaven

Treatment of Stage IIIA Non-Small Cell Lung Cancer

Surgery, radiation, and systemic chemotherapy - precision cancer medicines are all used to treat stage IIIA NSCLC

Cancer Connect

by

petro

Imfinzi Treatment for Stage III NSCLC Reduces Recurrence & Prolongs Survival

Imfinzi immunotherapy significantly improves treatment of stage III NSCLC - 50% of patients survive 4 years .

Cancer Connect

Gavreto Treatment for RET Fusion-Positive Non-Small Cell Lung Cancer

Gavreto now FDA approved for the treatment of RET positive NSCLC

MedMaven

Treatment of Stage II Non-Small Cell Lung Cancer

Consists of surgery, radiation & adjuvant therapy & precision medicines - immunotherapy are being incorporated.

Cancer Connect

by

dominick2

Tecentriq® Improves Survival in Newly Diagnosed and Recurrent NSCLC

The Tecentriq® Checkpoint Inhibitor Improves NSCLC survival when used alone and when combined with Avastin-chemotherapy.

Cancer Connect

In Depth Overview of Tyrosine Kinase Inhibitor Treatment of EGFR + Lung Cancer

TKI therapy for EGFR + NSCLC continue to evolve and improve survival. Tagrisso resistance mutation recently identified.

Cancer Connect

Zepzelca (Lurbinectedin) Active in Treatment of Small Cell Lung Cancer

The new drug Lurbinectedin appears active in the treatment of small cell lung cancer and was FDA approved in June 2020.

MedMaven